Analysen von Peter Welford
| 31.10.23 | QIAGEN Hold | Jefferies & Company Inc. | |
| 30.10.23 | Sanofi Buy | Jefferies & Company Inc. | |
| 27.10.23 | Sanofi Buy | Jefferies & Company Inc. | |
| 24.10.23 | Novartis Buy | Jefferies & Company Inc. | |
| 19.10.23 | Roche Hold | Jefferies & Company Inc. | |
| 13.10.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 11.10.23 | GSK Hold | Jefferies & Company Inc. | |
| 11.10.23 | Roche Hold | Jefferies & Company Inc. | |
|
Werbung
|
|||
| 11.10.23 | Novartis Buy | Jefferies & Company Inc. | |
| 25.09.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 25.09.23 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 05.09.23 | Novartis Buy | Jefferies & Company Inc. | |
| 10.08.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 09.08.23 | QIAGEN Hold | Jefferies & Company Inc. | |
| 08.08.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 28.07.23 | EVOTEC Buy | Jefferies & Company Inc. | |
| 27.07.23 | Roche Hold | Jefferies & Company Inc. | |
| 26.07.23 | GSK Hold | Jefferies & Company Inc. | |
| 18.07.23 | Novartis Buy | Jefferies & Company Inc. | |
| 05.07.23 | Sanofi Buy | Jefferies & Company Inc. | |
| 05.07.23 | Roche Hold | Jefferies & Company Inc. | |
| 05.07.23 | Novartis Buy | Jefferies & Company Inc. | |
| 05.07.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 05.07.23 | GSK Hold | Jefferies & Company Inc. | |
| 05.07.23 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 27.06.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 26.06.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 09.06.23 | Novartis Buy | Jefferies & Company Inc. | |
| 08.06.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 08.06.23 | QIAGEN Hold | Jefferies & Company Inc. | |
| 08.06.23 | Roche Hold | Jefferies & Company Inc. | |
| 02.06.23 | Novartis Buy | Jefferies & Company Inc. | |
| 01.06.23 | EVOTEC Buy | Jefferies & Company Inc. | |
| 22.05.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 11.05.23 | Merck Buy | Jefferies & Company Inc. | |
| 10.05.23 | EVOTEC Buy | Jefferies & Company Inc. | |
| 04.05.23 | QIAGEN Hold | Jefferies & Company Inc. | |
| 04.05.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 02.05.23 | Novartis Buy | Jefferies & Company Inc. | |
| 26.04.23 | Roche Hold | Jefferies & Company Inc. | |
| 25.04.23 | Novartis Buy | Jefferies & Company Inc. | |
| 18.04.23 | Sanofi Buy | Jefferies & Company Inc. | |
| 18.04.23 | Roche Hold | Jefferies & Company Inc. | |
| 18.04.23 | Novartis Buy | Jefferies & Company Inc. | |
| 18.04.23 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 18.04.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 13.04.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 28.03.23 | EVOTEC Buy | Jefferies & Company Inc. | |
| 27.03.23 | Novartis Buy | Jefferies & Company Inc. | |
| 23.03.23 | Sanofi Buy | Jefferies & Company Inc. | |